A
HUMAN NECESSITIES
HEALTH; LIFE-SAVING; AMUSEMENT
A61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J 3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

Note(s) [2006.01]

  • This subclass covers the following subject matter, whether set forth as a composition (mixture), process of preparing the composition or process of treating using the composition:
    • Drug or other biological compositions which are capable of:
      • preventing, alleviating, treating or curing abnormal or pathological conditions of the living body by such means as destroying a parasitic organism, or limiting the effect of the disease or abnormality by chemically altering the physiology of the host or parasite (biocides A01N 25/00-A01N 65/00);
      • maintaining, increasing, decreasing, limiting, or destroying a physiological body function, e.g. vitamin compositions, sex sterilants, fertility inhibitors, growth promotors, or the like (sex sterilants for invertebrates, e.g. insects, A01N; plant growth regulators A01N 25/00-A01N 65/00);
      • diagnosing a physiological condition or state by an in vivo test, e.g. X-ray contrast or skin patch test compositions (measuring or testing processes involving enzymes or microorganisms C12Q; in vitro testing of biological material, e.g. blood, urine, G01N, e.g. G01N 33/48);
    • Body treating compositions generally intended for deodorising, protecting, adorning or grooming a body, e.g. cosmetics, dentifrices, tooth filling materials.
  • Attention is drawn to the definitions of groups of chemical elements following the title of section C.
  • Attention is drawn to the notes in class C07, for example the notes following the title of the subclass C07D, setting forth the rules for classifying organic compounds in that class, which rules are also applicable, if not otherwise indicated, to the classification of organic compounds in A61K.
  • In this subclass, with the exception of group A61K 8/00, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.
  • Therapeutic activity of medicinal preparations is further classified in subclass A61P.
Subclass index
DENTAL PREPARATIONS 6/00
COSMETICS, PERFUMES 8/00
PHARMACEUTICAL PREPARATIONS
characterised by form 9/00
characterised by active ingredients
organic active ingredients 31/00, 35/00, 36/00, 38/00
materials from animals, protozoa, bacteria or viruses 35/00
materials from algae, fungi lichens or plants 36/00
inorganic active ingredients 33/00, 35/00
obtained by treating material with wave energy or particle radiation 41/00
for testing in vivo 49/00, 51/00
radioactive ingredients 51/00
Vaccines 39/00, 45/00
Carriers 47/00
Medicinal preparations with genetic material, gene therapy 48/00
A61K 6/00
Preparations for dentistry (teeth cleaning preparations A61K 8/00, A61Q 11/00; fastening dental prostheses in the mouth using adhesive foils or adhesive compositions A61C 13/23) [2006.01]
A61K 6/02
Use of preparations for artificial teeth, for filling or for capping teeth [2006.01]
A61K 6/027
Use of non-metallic elements or compounds thereof, e.g. carbon [2006.01]
A61K 6/033
Phosphorus compounds, e.g. apatite [2006.01]
A61K 6/04
Use of metals or alloys [2006.01]
A61K 6/05
Amalgams [2006.01]
A61K 6/06
Use of inorganic cements [2006.01]
A61K 6/08
Use of natural or synthetic resins [2006.01]
A61K 6/083
Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds [2006.01]
A61K 6/087
Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [2006.01]
A61K 6/09
Polyurethanes [2006.01]
A61K 6/093
Polyorganosilicon compounds [2006.01]
A61K 6/097
Polysaccharides [2006.01]
A61K 6/10
Compositions for taking dental impressions [2006.01]
A61K 8/00
Cosmetics or similar toilet preparations [2006.01]

Note(s) [2006.01]

  • Use of cosmetics or similar toilet preparations is further classified in subclass A61Q.
A61K 8/02
characterised by special physical form [2006.01]

Note(s) [2006.01]

  • In this group, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication of the contrary, classification is made in the last appropriate place.
A61K 8/03
Liquid compositions with two or more distinct layers [2006.01]
A61K 8/04
Dispersions; Emulsions [2006.01]
A61K 8/06
Emulsions [2006.01]
A61K 8/11
Encapsulated compositions [2006.01]
A61K 8/14
Liposomes [2006.01]
A61K 8/18
characterised by the composition [2006.01]

Note(s) [2006.01]

  • In this group, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication of the contrary, classification is made in the last appropriate place.
A61K 8/19
containing inorganic ingredients [2006.01]
A61K 8/20
Halogens; Compounds thereof [2006.01]
A61K 8/21
Fluorides; Derivatives thereof [2006.01]
A61K 8/22
Peroxides; Oxygen; Ozone [2006.01]
A61K 8/23
Sulfur; Selenium; Tellurium; Compounds thereof [2006.01]
A61K 8/24
Phosphorus; Compounds thereof [2006.01]
A61K 8/25
Silicon; Compounds thereof [2006.01]
A61K 8/26
Aluminium; Compounds thereof [2006.01]
A61K 8/27
Zinc; Compounds thereof [2006.01]
A61K 8/28
Zirconium; Compounds thereof [2006.01]
A61K 8/29
Titanium; Compounds thereof [2006.01]
A61K 8/30
containing organic compounds [2006.01]
A61K 8/31
Hydrocarbons [2006.01]
A61K 8/33
containing oxygen [2006.01]
A61K 8/34
Alcohols [2006.01]
A61K 8/35
Ketones, e.g. quinones, benzophenone [2006.01]
A61K 8/36
Carboxylic acids; Salts or anhydrides thereof [2006.01]
A61K 8/362
Polycarboxylic acids [2006.01]
A61K 8/365
Hydroxycarboxylic acids; Ketocarboxylic acids [2006.01]
A61K 8/368
with carboxyl groups directly bound to carbon atoms of aromatic rings [2006.01]
A61K 8/37
Esters of carboxylic acids [2006.01]
A61K 8/38
Percompounds, e.g. peracids [2006.01]
A61K 8/39
Derivatives containing from 2 to 10 oxyalkylene groups [2006.01]
A61K 8/40
containing nitrogen (quinones containing nitrogen A61K 8/35) [2006.01]
A61K 8/41
Amines [2006.01]
A61K 8/42
Amides [2006.01]
A61K 8/43
Guanidines [2006.01]
A61K 8/44
Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof [2006.01]
A61K 8/45
Derivatives containing from 2 to 10 oxyalkylene groups [2006.01]
A61K 8/46
containing sulfur (A61K 8/44 takes precedence) [2006.01]
A61K 8/49
containing heterocyclic compounds [2006.01]
A61K 8/55
containing phosphorus [2006.01]
A61K 8/58
containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus [2006.01]
A61K 8/60
Sugars; Derivatives thereof [2006.01]
A61K 8/63
Steroids; Derivatives thereof [2006.01]

Note(s) [2006.01]

  • This group covers steroids, as defined in Note (1) after the title of subclass C07J.
A61K 8/64
Proteins; Peptides; Derivatives or degradation products thereof [2006.01]
A61K 8/65
Collagen; Gelatin; Keratin; Derivatives or degradation products thereof [2006.01]
A61K 8/66
Enzymes [2006.01]
A61K 8/67
Vitamins [2006.01]
A61K 8/68
Sphingolipids, e.g. ceramides, cerebrosides, gangliosides [2006.01]
A61K 8/69
containing fluorine [2006.01]
A61K 8/70
containing perfluoro groups, e.g. perfluoroethers [2006.01]
A61K 8/72
containing organic macromolecular compounds [2006.01]
A61K 8/73
Polysaccharides [2006.01]
A61K 8/81
obtained by reactions involving only carbon-to-carbon unsaturated bonds [2006.01]
A61K 8/84
obtained by reactions other than those involving only carbon-to-carbon unsaturated bonds [2006.01]
A61K 8/85
Polyesters [2006.01]
A61K 8/86
Polyethers [2006.01]
A61K 8/87
Polyurethanes [2006.01]
A61K 8/88
Polyamides [2006.01]
A61K 8/89
Polysiloxanes [2006.01]
A61K 8/891
saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone [2006.01]
A61K 8/892
modified by a hydroxy group, e.g. dimethiconol [2006.01]
A61K 8/893
modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone [2006.01]
A61K 8/894
modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol [2006.01]
A61K 8/895
containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone [2006.01]
A61K 8/896
containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate [2006.01]
A61K 8/897
containing halogen, e.g. fluorosilicones [2006.01]
A61K 8/898
containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine [2006.01]
A61K 8/899
containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol [2006.01]
A61K 8/90
Block copolymers (A61K 8/89 takes precedence) [2006.01]
A61K 8/91
Graft copolymers (A61K 8/89 takes precedence) [2006.01]
A61K 8/92
Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products [2006.01]
A61K 8/96
containing materials, or derivatives thereof, of undetermined constitution [2006.01]
A61K 8/97
from algae, fungi, lichens or plants; from derivatives thereof [2017.01]
A61K 8/9706
Algae [2017.01]
A61K 8/9711
Phaeophycota or Phaeophyta [brown algae], e.g. Fucus [2017.01]
A61K 8/9717
Rhodophycota or Rhodophyta [red algae], e.g. Porphyra [2017.01]
A61K 8/9722
Chlorophycota or Chlorophyta [green algae], e.g. Chlorella [2017.01]
A61K 8/9728
Fungi, e.g. yeasts [2017.01]
A61K 8/9733
Lichens [2017.01]
A61K 8/9739
Bryophyta [mosses] [2017.01]
A61K 8/9741
Pteridophyta [ferns] [2017.01]
A61K 8/9749
Filicopsida or Pteridopsida [2017.01]
A61K 8/9755
Gymnosperms [Coniferophyta] [2017.01]
A61K 8/9761
Cupressaceae [Cypress family], e.g. juniper or cypress [2017.01]
A61K 8/9767
Pinaceae [Pine family], e.g. pine or cedar [2017.01]
A61K 8/9771
Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family] [2017.01]
A61K 8/9778
Gnetophyta, e.g. Ephedraceae [Mormon-tea family] [2017.01]
A61K 8/9783
Angiosperms [Magnoliophyta] [2017.01]
A61K 8/9789
Magnoliopsida [dicotyledons] [2017.01]
A61K 8/9794
Liliopsida [monocotyledons] [2017.01]
A61K 8/98
of animal origin [2006.01]
A61K 8/99
from microorganisms other than algae or fungi, e.g. protozoa or bacteria [2017.01]
A61K 9/00
Medicinal preparations characterised by special physical form [2006.01]
A61K 9/02
Suppositories; Bougies; Bases for suppositories or bougies (apparatus for making A61J 3/08; devices for introducing into the body A61M 31/00) [2006.01]
A61K 9/06
Ointments; Bases therefor (apparatus for making A61J 3/04) [2006.01]
A61K 9/08
Solutions [2006.01]
A61K 9/10
Dispersions; Emulsions [2006.01]
A61K 9/107
Emulsions [2006.01]
A61K 9/113
Multiple emulsions, e.g. oil-in-water-in-oil [2006.01]
A61K 9/12
Aerosols; Foams [2006.01]
A61K 9/127
Liposomes [2006.01]
A61K 9/133
Unilamellar vesicles [2006.01]
A61K 9/14
Particulate form, e.g. powders (microcapsules A61K 9/50) [2006.01]
A61K 9/16
Agglomerates; Granulates; Microbeadlets [2006.01]
A61K 9/18
Adsorbates [2006.01]
A61K 9/19
lyophilised [2006.01]
A61K 9/20
Pills, lozenges or tablets [2006.01]
A61K 9/22
Sustained or differential release type [2006.01]
A61K 9/24
Layered or laminated unitary dosage forms [2006.01]
A61K 9/26
Discrete particles in supporting matrix [2006.01]
A61K 9/28
Dragees; Coated pills or tablets [2006.01]
A61K 9/30
Organic coatings [2006.01]
A61K 9/32
containing solid synthetic polymers [2006.01]
A61K 9/34
containing natural gums or resins [2006.01]
A61K 9/36
containing carbohydrates or derivatives thereof (A61K 9/34 takes precedence) [2006.01]
A61K 9/38
containing proteins or derivatives thereof [2006.01]
A61K 9/40
Gelatin containing [2006.01]
A61K 9/42
containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate [2006.01]
A61K 9/44
printed, embossed, grooved, or perforated [2006.01]
A61K 9/46
effervescent [2006.01]
A61K 9/48
Preparations in capsules, e.g. of gelatin, of chocolate [2006.01]
A61K 9/50
Microcapsules (A61K 9/52 takes precedence) [2006.01]
A61K 9/51
Nanocapsules [2006.01]
A61K 9/52
Sustained or differential release type [2006.01]
A61K 9/54
containing discrete particles with coatings of different thicknesses or different materials [2006.01]
A61K 9/56
Organic coatings [2006.01]
A61K 9/58
containing solid synthetic polymers [2006.01]
A61K 9/60
containing natural gums or resins [2006.01]
A61K 9/62
containing carbohydrates or derivatives thereof (A61K 9/60 takes precedence) [2006.01]
A61K 9/64
containing proteins or derivatives thereof [2006.01]
A61K 9/66
containing emulsions, dispersions or solutions [2006.01]
A61K 9/68
chewing gum type [2006.01]
A61K 9/70
Web, sheet or filament bases [2006.01]
A61K 9/72
for smoking or inhaling [2006.01]

Note(s) [2006.01]

  • A composition, i.e. a mixture of two or more components, is classified in the last of groups A61K 31/00-A61K 47/00 that provides for at least one of these components. The components may be single compounds or other single ingredients.
  • Any part of a composition which is not identified by the classification according to Note (1), and which itself is determined to be novel and non-obvious, must also be classified in the last appropriate place in groups A61K 31/00-A61K 47/00. The part can be either a single component or a composition in itself.
  • Any part of a composition which is not identified by the classification according to Note (1) or (2), and which is considered to represent information of interest for search, may also be classified in the last appropriate place in groups A61K 31/00-A61K 47/00. This can for example be the case when it is considered of interest to enable searching of compositions using a combination of classification symbols. Such non-obligatory classification should be given as "additional information".
A61K 31/00
Medicinal preparations containing organic active ingredients [2006.01]

Note(s) [7]

  • Organic active compounds forming salts or complexes with heavy metals are not classified in groups A61K 31/28, A61K 31/555 or A61K 31/7135, unless explicit indication to the contrary is made, e.g. hemin A61K 31/555.
  • In this group, the expressions "containing further heterocyclic rings" and "condensed with heterocyclic rings" also cover compounds having two or more identical heterocyclic rings.
A61K 31/01
Hydrocarbons [2006.01]
A61K 31/015
carbocyclic [2006.01]
A61K 31/02
Halogenated hydrocarbons [2006.01]
A61K 31/025
carbocyclic [2006.01]
A61K 31/03
aromatic [2006.01]
A61K 31/035
having aliphatic unsaturation [2006.01]
A61K 31/04
Nitro compounds [2006.01]
A61K 31/045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates (hydroperoxides A61K 31/327) [2006.01]
A61K 31/047
having two or more hydroxy groups, e.g. sorbitol [2006.01]
A61K 31/05
Phenols [2006.01]
A61K 31/055
the aromatic ring being substituted by halogen [2006.01]
A61K 31/06
the aromatic ring being substituted by nitro groups [2006.01]
A61K 31/065
Diphenyl-substituted acyclic alcohols [2006.01]
A61K 31/07
Retinol compounds, e.g. vitamin A (retinoic acids A61K 31/203) [2006.01]
A61K 31/075
Ethers or acetals [2006.01]
A61K 31/08
acyclic, e.g. paraformaldehyde [2006.01]
A61K 31/085
having an ether linkage to aromatic ring nuclear carbon [2006.01]
A61K 31/09
having two or more such linkages [2006.01]
A61K 31/095
Sulfur, selenium or tellurium compounds, e.g. thiols [2006.01]
A61K 31/10
Sulfides; Sulfoxides; Sulfones [2006.01]
A61K 31/105
Persulfides (thiuram disulfides A61K 31/145; thiosulfonic acids A61K 31/185) [2006.01]
A61K 31/11
Aldehydes [2006.01]
A61K 31/115
Formaldehyde [2006.01]
A61K 31/12
Ketones [2006.01]
A61K 31/121
acyclic [2006.01]
A61K 31/122
having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin [2006.01]
A61K 31/125
Camphor; Nuclear substituted derivatives thereof [2006.01]
A61K 31/13
Amines, e.g. amantadine (A61K 31/04 takes precedence) [2006.01]
A61K 31/131
acyclic [2006.01]
A61K 31/132
having two or more amino groups, e.g. spermidine, putrescine [2006.01]
A61K 31/133
having hydroxy groups, e.g. sphingosine [2006.01]
A61K 31/135
having aromatic rings, e.g. methadone [2006.01]
A61K 31/136
having the amino group directly attached to the aromatic ring, e.g. benzeneamine [2006.01]
A61K 31/137
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine [2006.01]
A61K 31/138
Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine (atenolol A61K 31/165; pindolol A61K 31/404; timolol A61K 31/5377) [2006.01]
A61K 31/14
Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K 31/205) [2006.01]
A61K 31/145
having sulfur atoms, e.g. thiurams (llinktN—C(S)—S—C(S)—Nrlinkt or llinktN—C(S)—S—S—C(S)—Nrlinkt); Sulfinylamines (—N=SO); Sulfonylamines (—N=SO2) (isothioureas A61K 31/155) [2006.01]
A61K 31/15
Oximes (llinktC=N—O—); Hydrazines (llinktN—Nrlinkt); Hydrazones (llinktN—N=) [2006.01]
A61K 31/155
Amidines (fig701), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2) [2006.01]
A61K 31/16
Amides, e.g. hydroxamic acids [2006.01]
A61K 31/164
of a carboxylic acid with an aminoalcohol, e.g. ceramides [2006.01]
A61K 31/165
having aromatic rings, e.g. colchicine, atenolol, progabide [2006.01]
A61K 31/166
having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol [2006.01]
A61K 31/167
having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol [2006.01]
A61K 31/17
having the group llinktN—C(O)—Nrlinkt or llinktN—C(S)—Nrlinkt, e.g. urea, thiourea, carmustine (isoureas, isothioureas A61K 31/155; sulfonylureas A61K 31/64) [2006.01]
A61K 31/175
having the group fig702, llinktN—C(O)—N=N— or fig703, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof [2006.01]
A61K 31/18
Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N-group A61K 31/63) [2006.01]
A61K 31/185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K 31/16; peroxy acids A61K 31/327) [2006.01]
A61K 31/19
Carboxylic acids, e.g. valproic acid (salicylic acid A61K 31/60) [2006.01]
A61K 31/191
Acyclic acids having two or more hydroxy groups, e.g. gluconic acid [2006.01]
A61K 31/192
having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid [2006.01]
A61K 31/194
having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid [2006.01]
A61K 31/195
having an amino group [2006.01]

Note(s) [7]

  • In this group, the expression "amino group" also covers "acyl amino group".
A61K 31/196
the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil [2006.01]
A61K 31/197
the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid (carnitine A61K 31/205) [2006.01]
A61K 31/198
Alpha-amino acids, e.g. alanine, edetic acid (EDTA) (betaine A61K 31/205; proline A61K 31/401; tryptophan A61K 31/405; histidine A61K 31/4172; peptides not degraded to individual amino acids A61K 38/00) [2006.01]
A61K 31/20
having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid [2006.01]
A61K 31/201
having one or two double bonds, e.g. oleic or linoleic acid [2006.01]
A61K 31/202
having three or more double bonds, e.g. linolenic acid (eicosanoids, e.g. leukotrienes, A61K 31/557) [2006.01]
A61K 31/203
Retinoic acids [2006.01]
A61K 31/205
Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine [2006.01]
A61K 31/21
Esters, e.g. nitroglycerine, selenocyanates [2006.01]
A61K 31/215
of carboxylic acids [2006.01]
A61K 31/216
of acids having aromatic rings, e.g. benactizyne, clofibrate [2006.01]
A61K 31/22
of acyclic acids, e.g. pravastatin [2006.01]
A61K 31/221
with compounds having an amino group, e.g. acetylcholine, acetylcarnitine [2006.01]
A61K 31/222
with compounds having aromatic groups, e.g. dipivefrine, ibopamine [2006.01]
A61K 31/223
of alpha-amino acids [2006.01]
A61K 31/225
Polycarboxylic acids [2006.01]
A61K 31/23
of acids having a carboxyl group bound to a chain of seven or more carbon atoms [2006.01]
A61K 31/231
having one or two double bonds [2006.01]
A61K 31/232
having three or more double bonds, e.g. etretinate [2006.01]
A61K 31/235
having an aromatic ring attached to a carboxyl group [2006.01]
A61K 31/24
having an amino or nitro group [2006.01]
A61K 31/245
Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K 31/60) [2006.01]
A61K 31/25
with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol [2006.01]
A61K 31/255
of sulfoxy acids or sulfur analogues thereof [2006.01]
A61K 31/26
Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters [2006.01]
A61K 31/265
of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid [2006.01]
A61K 31/27
of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine [2006.01]
A61K 31/275
Nitriles; Isonitriles [2006.01]
A61K 31/277
having a ring, e.g. verapamil [2006.01]
A61K 31/28
Compounds containing heavy metals [2006.01]
A61K 31/282
Platinum compounds [2006.01]
A61K 31/285
Arsenic compounds [2006.01]
A61K 31/29
Antimony or bismuth compounds [2006.01]
A61K 31/295
Iron group metal compounds [2006.01]
A61K 31/30
Copper compounds [2006.01]
A61K 31/305
Mercury compounds [2006.01]
A61K 31/31
containing nitrogen [2006.01]
A61K 31/315
Zinc compounds [2006.01]
A61K 31/32
Tin compounds [2006.01]
A61K 31/325
Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams A61K 31/145) [2006.01]
A61K 31/327
Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids [2006.01]
A61K 31/33
Heterocyclic compounds [2006.01]
A61K 31/335
having oxygen as the only ring hetero atom, e.g. fungichromin [2006.01]
A61K 31/336
having three-membered rings, e.g. oxirane, fumagillin [2006.01]
A61K 31/337
having four-membered rings, e.g. taxol [2006.01]
A61K 31/34
having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide [2006.01]
A61K 31/341
not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine [2006.01]
A61K 31/343
condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone [2006.01]
A61K 31/345
Nitrofurans (nitrofurantoin A61K 31/4178) [2006.01]
A61K 31/35
having six-membered rings with one oxygen as the only ring hetero atom [2006.01]
A61K 31/351
not condensed with another ring [2006.01]
A61K 31/352
condensed with carbocyclic rings, e.g. cannabinols, methantheline [2006.01]
A61K 31/353
3,4-Dihydrobenzopyrans, e.g. chroman, catechin [2006.01]
A61K 31/355
Tocopherols, e.g. vitamin E [2006.01]
A61K 31/357
having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel [2006.01]
A61K 31/36
Compounds containing methylenedioxyphenyl groups, e.g. sesamin [2006.01]
A61K 31/365
Lactones [2006.01]
A61K 31/366
having six-membered rings, e.g. delta-lactones [2006.01]
A61K 31/37
Coumarins, e.g. psoralen [2006.01]
A61K 31/375
Ascorbic acid, i.e. vitamin C; Salts thereof [2006.01]
A61K 31/38
having sulfur as a ring hetero atom [2006.01]
A61K 31/381
having five-membered rings [2006.01]
A61K 31/382
having six-membered rings, e.g. thioxanthenes (thiothixene A61K 31/496) [2006.01]
A61K 31/385
having two or more sulfur atoms in the same ring [2006.01]
A61K 31/39
having oxygen atoms in the same ring [2006.01]
A61K 31/395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins (rifampin A61K 31/496) [2006.01]
A61K 31/396
having three-membered rings, e.g. aziridine [2006.01]
A61K 31/397
having four-membered rings, e.g. azetidine [2006.01]
A61K 31/40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil [2006.01]
A61K 31/401
Proline; Derivatives thereof, e.g. captopril [2006.01]
A61K 31/4015
having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide [2006.01]
A61K 31/402
1-aryl-substituted, e.g. piretanide [2006.01]
A61K 31/4025
not condensed and containing further heterocyclic rings, e.g. cromakalim [2006.01]
A61K 31/403
condensed with carbocyclic rings, e.g. carbazole [2006.01]
A61K 31/4035
Isoindoles, e.g. phthalimide [2006.01]
A61K 31/404
Indoles, e.g. pindolol [2006.01]
A61K 31/4045
Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin [2006.01]
A61K 31/405
Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin [2006.01]
A61K 31/407
condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine [2006.01]
A61K 31/409
having four such rings, e.g. porphine derivatives, bilirubin, biliverdine (hemin, hematin A61K 31/555) [2006.01]
A61K 31/41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole [2006.01]
A61K 31/415
1,2-Diazoles [2006.01]
A61K 31/4152
having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone [2006.01]
A61K 31/4155
not condensed and containing further heterocyclic rings [2006.01]
A61K 31/416
condensed with carbocyclic ring systems, e.g. indazole [2006.01]
A61K 31/4162
condensed with heterocyclic ring systems [2006.01]
A61K 31/4164
1,3-Diazoles [2006.01]
A61K 31/4166
having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin [2006.01]
A61K 31/4168
having a nitrogen atom attached in position 2, e.g. clonidine [2006.01]
A61K 31/417
Imidazole-alkylamines, e.g. histamine, phentolamine [2006.01]
A61K 31/4172
Imidazole-alkanecarboxylic acids, e.g. histidine [2006.01]
A61K 31/4174
Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole [2006.01]
A61K 31/4178
not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin [2006.01]
A61K 31/4184
condensed with carbocyclic rings, e.g. benzimidazoles [2006.01]
A61K 31/4188
condensed with heterocyclic ring systems, e.g. biotin, sorbinil [2006.01]
A61K 31/4192
1,2,3-Triazoles [2006.01]
A61K 31/4196
1,2,4-Triazoles [2006.01]
A61K 31/42
Oxazoles [2006.01]
A61K 31/421
1,3-Oxazoles, e.g. pemoline, trimethadione [2006.01]
A61K 31/422
not condensed and containing further heterocyclic rings [2006.01]
A61K 31/423
condensed with carbocyclic rings [2006.01]
A61K 31/424
condensed with heterocyclic ring systems, e.g. clavulanic acid [2006.01]
A61K 31/4245
Oxadiazoles [2006.01]
A61K 31/425
Thiazoles [2006.01]
A61K 31/426
1,3-Thiazoles [2006.01]
A61K 31/427
not condensed and containing further heterocyclic rings [2006.01]
A61K 31/428
condensed with carbocyclic rings [2006.01]
A61K 31/429
condensed with heterocyclic ring systems [2006.01]
A61K 31/43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula fig604, e.g. penicillins, penems [2006.01]
A61K 31/431
containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin [2006.01]
A61K 31/433
Thiadiazoles [2006.01]
A61K 31/435
having six-membered rings with one nitrogen as the only ring hetero atom [2006.01]
A61K 31/4353
ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/4355
the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom [2006.01]
A61K 31/436
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin [2006.01]
A61K 31/4365
the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine [2006.01]
A61K 31/437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline [2006.01]
A61K 31/4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine [2006.01]
A61K 31/438
the ring being spiro-condensed with carbocyclic or heterocyclic ring systems [2006.01]
A61K 31/439
the ring forming part of a bridged ring system, e.g. quinuclidine (8-azabicyclo [3.2.1] octanes A61K 31/46) [2006.01]
A61K 31/44
Non-condensed pyridines; Hydrogenated derivatives thereof [2006.01]
A61K 31/4402
only substituted in position 2, e.g. pheniramine, bisacodyl [2006.01]
A61K 31/4406
only substituted in position 3, e.g. zimeldine (nicotinic acid A61K 31/455) [2006.01]
A61K 31/4409
only substituted in position 4, e.g. isoniazid, iproniazid [2006.01]
A61K 31/4412
having oxo groups directly attached to the heterocyclic ring [2006.01]
A61K 31/4415
Pyridoxine, i.e.vitamin B6 (pyridoxal phosphate A61K 31/675) [2006.01]
A61K 31/4418
having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine [2006.01]
A61K 31/4422
1,4-Dihydropyridines, e.g. nifedipine, nicardipine [2006.01]
A61K 31/4425
Pyridinium derivatives, e.g. pralidoxime, pyridostigmine [2006.01]
A61K 31/4427
containing further heterocyclic ring systems [2006.01]
A61K 31/443
containing a five-membered ring with oxygen as a ring hetero atom [2006.01]
A61K 31/4433
containing a six-membered ring with oxygen as a ring hetero atom [2006.01]
A61K 31/4436
containing a heterocyclic ring having sulfur as a ring hetero atom [2006.01]
A61K 31/4439
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K 31/465) [2006.01]
A61K 31/444
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone [2006.01]
A61K 31/445
Non-condensed piperidines, e.g. piperocaine [2006.01]
A61K 31/4453
only substituted in position 1, e.g. propipocaine, diperodon [2006.01]
A61K 31/4458
only substituted in position 2, e.g. methylphenidate [2006.01]
A61K 31/4462
only substituted in position 3 [2006.01]
A61K 31/4465
only substituted in position 4 [2006.01]
A61K 31/4468
having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl [2006.01]
A61K 31/45
having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide [2006.01]
A61K 31/451
having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine [2006.01]
A61K 31/4515
having a butyrophenone group in position 1, e.g. haloperidol (pipamperone A61K 31/4545) [2006.01]
A61K 31/452
Piperidinium derivatives (pancuronium A61K 31/58) [2006.01]
A61K 31/4523
containing further heterocyclic ring systems [2006.01]
A61K 31/4525
containing a five-membered ring with oxygen as a ring hetero atom [2006.01]
A61K 31/453
containing a six-membered ring with oxygen as a ring hetero atom [2006.01]
A61K 31/4535
containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen [2006.01]
A61K 31/454
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone [2006.01]
A61K 31/4545
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine [2006.01]
A61K 31/455
Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides [2006.01]
A61K 31/46
8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine [2006.01]
A61K 31/465
Nicotine; Derivatives thereof [2006.01]
A61K 31/47
Quinolines; Isoquinolines [2006.01]
A61K 31/4704
2-Quinolinones, e.g. carbostyril [2006.01]
A61K 31/4706
4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine [2006.01]
A61K 31/4709
Non-condensed quinolines containing further heterocyclic rings [2006.01]
A61K 31/472
Non-condensed isoquinolines, e.g. papaverine [2006.01]
A61K 31/4725
containing further heterocyclic rings [2006.01]
A61K 31/473
ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines [2006.01]
A61K 31/4738
ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/4741
condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline [2006.01]
A61K 31/4743
condensed with ring systems having sulfur as a ring hetero atom [2006.01]
A61K 31/4745
condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines (yohimbine derivatives, vinblastine A61K 31/475; ergoline derivatives A61K 31/48) [2006.01]
A61K 31/4747
spiro-condensed [2006.01]
A61K 31/4748
forming part of bridged ring systems (strychnine A61K 31/475; morphinan derivatives A61K 31/485) [2006.01]
A61K 31/475
having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine (vincamine A61K 31/4375) [2006.01]
A61K 31/48
Ergoline derivatives, e.g. lysergic acid, ergotamine [2006.01]
A61K 31/485
Morphinan derivatives, e.g. morphine, codeine [2006.01]
A61K 31/49
Cinchonan derivatives, e.g. quinine [2006.01]
A61K 31/495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine (A61K 31/48 takes precedence) [2006.01]
A61K 31/496
Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene [2006.01]
A61K 31/4965
Non-condensed pyrazines [2006.01]
A61K 31/497
containing further heterocyclic rings [2006.01]
A61K 31/498
Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine [2006.01]
A61K 31/4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/499
Spiro-condensed pyrazines or piperazines [2006.01]
A61K 31/4995
Pyrazines or piperazines forming part of bridged ring systems [2006.01]
A61K 31/50
Pyridazines; Hydrogenated pyridazines [2006.01]
A61K 31/501
not condensed and containing further heterocyclic rings [2006.01]
A61K 31/502
ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine [2006.01]
A61K 31/5025
ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/503
spiro-condensed [2006.01]
A61K 31/504
forming part of bridged ring systems [2006.01]
A61K 31/505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim [2006.01]
A61K 31/506
not condensed and containing further heterocyclic rings [2006.01]
A61K 31/51
Thiamines, e.g. vitamin B1 [2006.01]
A61K 31/513
having oxo groups directly attached to the heterocyclic ring, e.g. cytosine [2006.01]
A61K 31/515
Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital [2006.01]
A61K 31/517
ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine [2006.01]
A61K 31/519
ortho- or peri-condensed with heterocyclic rings [2006.01]
A61K 31/52
Purines, e.g. adenine [2006.01]
A61K 31/522
having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir [2006.01]
A61K 31/525
Isoalloxazines, e.g. riboflavins, vitamin B2 [2006.01]
A61K 31/527
spiro-condensed [2006.01]
A61K 31/529
forming part of bridged ring systems [2006.01]
A61K 31/53
having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine (melarsoprol A61K 31/555) [2006.01]
A61K 31/535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines [2006.01]
A61K 31/5355
Non-condensed oxazines containing further heterocyclic rings [2006.01]
A61K 31/536
ortho- or peri-condensed with carbocyclic ring systems [2006.01]
A61K 31/5365
ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/537
spiro-condensed or forming part of bridged ring systems [2006.01]
A61K 31/5375
1,4-Oxazines, e.g. morpholine [2006.01]
A61K 31/5377
not condensed and containing further heterocyclic rings, e.g. timolol [2006.01]
A61K 31/538
ortho- or peri-condensed with carbocyclic ring systems [2006.01]
A61K 31/5383
ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/5386
spiro-condensed or forming part of bridged ring systems [2006.01]
A61K 31/539
having two or more oxygen atoms in the same ring, e.g dioxazines [2006.01]
A61K 31/5395
having two or more nitrogen atoms in the same ring, e.g. oxadiazines [2006.01]
A61K 31/54
having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame [2006.01]
A61K 31/541
Non-condensed thiazines containing further heterocyclic rings [2006.01]
A61K 31/5415
ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam [2006.01]
A61K 31/542
ortho- or peri-condensed with heterocyclic ring systems [2006.01]
A61K 31/545
Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula fig605, e.g. cephalosporins, cefaclor, cephalexine [2006.01]
A61K 31/546
containing further heterocyclic rings, e.g. cephalothin [2006.01]
A61K 31/547
spiro-condensed or forming part of bridged ring systems [2006.01]
A61K 31/548
having two or more sulfur atoms in the same ring [2006.01]
A61K 31/549
having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide [2006.01]
A61K 31/55
having seven-membered rings, e.g. azelastine, pentylenetetrazole [2006.01]
A61K 31/551
having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep [2006.01]
A61K 31/5513
1,4-Benzodiazepines, e.g. diazepam [2006.01]
A61K 31/5517
condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam [2006.01]
A61K 31/553
having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine [2006.01]
A61K 31/554
having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem [2006.01]
A61K 31/555
containing heavy metals, e.g. hemin, hematin, melarsoprol [2006.01]
A61K 31/557
Eicosanoids, e.g. leukotrienes [2006.01]
A61K 31/5575
having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha [2006.01]
A61K 31/5578
having a pentalene ring system, e.g. carbacyclin, iloprost [2006.01]
A61K 31/558
having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes [2006.01]
A61K 31/5585
having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin [2006.01]
A61K 31/559
having heterocyclic rings containing hetero atoms other than oxygen [2006.01]
A61K 31/56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids [2006.01]

Note(s) [7]

  • Attention is drawn to Note (1) following the title of subclass C07J, which explains what is covered by the term "steroids".
A61K 31/565
not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol [2006.01]
A61K 31/566
having an oxo group in position 17, e.g. oestrone [2006.01]
A61K 31/567
substituted in position 17 alpha, e.g. mestranol, norethandrolone [2006.01]
A61K 31/568
substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone [2006.01]
A61K 31/5685
having an oxo group in position 17, e.g. androsterone [2006.01]
A61K 31/569
substituted in position 17 alpha, e.g. ethisterone [2006.01]
A61K 31/57
substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone [2006.01]
A61K 31/573
substituted in position 21, e.g. cortisone, dexamethasone, prednisone [2006.01]
A61K 31/575
substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol [2006.01]
A61K 31/58
containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin (digitoxin A61K 31/704) [2006.01]
A61K 31/585
containing lactone rings, e.g. oxandrolone, bufalin [2006.01]
A61K 31/59
Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems [2006.01]
A61K 31/592
9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2 [2006.01]
A61K 31/593
9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3 [2006.01]
A61K 31/60
Salicylic acid; Derivatives thereof [2006.01]
A61K 31/603
having further aromatic rings, e.g. diflunisal [2006.01]
A61K 31/606
having amino groups [2006.01]
A61K 31/609
Amides, e.g. salicylamide [2006.01]
A61K 31/612
having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid (fosfosal A61K 31/661) [2006.01]
A61K 31/616
by carboxylic acids, e.g. acetylsalicylic acid [2006.01]
A61K 31/618
having the carboxyl group in position 1 esterified, e.g. salsalate [2006.01]
A61K 31/621
having the hydroxy group in position 2 esterified, e.g. benorylate [2006.01]
A61K 31/625
having heterocyclic substituents, e.g. 4-salicyloylmorpholine (sulfasalazine A61K 31/635) [2006.01]
A61K 31/63
Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide [2006.01]
A61K 31/635
having a heterocyclic ring, e.g. sulfadiazine [2006.01]
A61K 31/64
Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide [2006.01]
A61K 31/65
Tetracyclines [2006.01]
A61K 31/655
Azo (—N=N—), diazo (=N2), azoxy (llinktN—O—Nrlinkt or N(=O)—Nrlinkt), azido (—N3) or diazoamino (—N=N—Nrlinkt) compounds [2006.01]
A61K 31/66
Phosphorus compounds [2006.01]
A61K 31/661
Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion [2006.01]
A61K 31/6615
Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid [2006.01]
A61K 31/662
Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon [2006.01]
A61K 31/663
Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid [2006.01]
A61K 31/664
Amides of phosphorus acids [2006.01]
A61K 31/665
having oxygen as a ring hetero atom, e.g. fosfomycin [2006.01]
A61K 31/67
having sulfur as a ring hetero atom [2006.01]
A61K 31/675
having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate [2006.01]
A61K 31/683
Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols [2006.01]
A61K 31/685
one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin [2006.01]
A61K 31/688
both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins [2006.01]
A61K 31/69
Boron compounds [2006.01]
A61K 31/695
Silicon compounds [2006.01]
A61K 31/70
Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K 31/047) [2006.01]

Note(s) [7]

  • In this group, the expressions are used with the meanings indicated in Note (3) following the title of subclass C07H.
A61K 31/7004
Monosaccharides having only carbon, hydrogen and oxygen atoms [2006.01]
A61K 31/7008
Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine [2006.01]
A61K 31/7012
Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid (gluconic acid A61K 31/191; ascorbic acid A61K 31/375) [2006.01]
A61K 31/7016
Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K 31/7032) [2006.01]
A61K 31/702
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages [2006.01]
A61K 31/7024
Esters of saccharides [2006.01]
A61K 31/7028
Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages [2006.01]
A61K 31/7032
attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides [2006.01]
A61K 31/7034
attached to a carbocyclic compound, e.g. phloridzin [2006.01]
A61K 31/7036
having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins [2006.01]
A61K 31/704
attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin [2006.01]
A61K 31/7042
Compounds having saccharide radicals and heterocyclic rings [2006.01]
A61K 31/7048
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin [2006.01]
A61K 31/7052
having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides [2006.01]
A61K 31/7056
containing five-membered rings with nitrogen as a ring hetero atom [2006.01]
A61K 31/706
containing six-membered rings with nitrogen as a ring hetero atom [2006.01]
A61K 31/7064
containing condensed or non-condensed pyrimidines [2006.01]
A61K 31/7068
having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid [2006.01]
A61K 31/7072
having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine [2006.01]
A61K 31/7076
containing purines, e.g. adenosine, adenylic acid [2006.01]
A61K 31/708
having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid [2006.01]
A61K 31/7084
Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide [2006.01]
A61K 31/7088
Compounds having three or more nucleosides or nucleotides [2006.01]
A61K 31/7105
Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links [2006.01]
A61K 31/711
Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links [2006.01]
A61K 31/7115
Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine [2006.01]
A61K 31/712
Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose [2006.01]
A61K 31/7125
Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters [2006.01]
A61K 31/713
Double-stranded nucleic acids or oligonucleotides [2006.01]
A61K 31/7135
Compounds containing heavy metals [2006.01]
A61K 31/714
Cobalamins, e.g. cyanocobalamin, vitamin B12 [2006.01]
A61K 31/715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters [2006.01]
A61K 31/716
Glucans [2006.01]
A61K 31/717
Celluloses [2006.01]
A61K 31/718
Starch or degraded starch, e.g. amylose, amylopectin [2006.01]
A61K 31/719
Pullulans [2006.01]
A61K 31/721
Dextrans [2006.01]
A61K 31/722
Chitin; Chitosan [2006.01]
A61K 31/723
Xanthans [2006.01]
A61K 31/724
Cyclodextrins [2006.01]
A61K 31/726
Glycosaminoglycans, i.e. mucopolysaccharides (chondroitin sulfate, dermatan sulfate A61K 31/737) [2006.01]
A61K 31/727
Heparin; Heparan [2006.01]
A61K 31/728
Hyaluronic acid [2006.01]
A61K 31/729
Agar; Agarose; Agaropectin [2006.01]
A61K 31/731
Carrageenans [2006.01]
A61K 31/732
Pectin [2006.01]
A61K 31/733
Fructosans, e.g. inulin [2006.01]
A61K 31/734
Alginic acid [2006.01]
A61K 31/736
Glucomannans or galactomannans, e.g locust bean gum, guar gum [2006.01]
A61K 31/737
Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K 31/727 takes precedence) [2006.01]
A61K 31/738
Cross-linked polysaccharides [2006.01]
A61K 31/739
Lipopolysaccharides [2006.01]
A61K 31/74
Synthetic polymeric materials [2006.01]
A61K 31/745
Polymers of hydrocarbons [2006.01]
A61K 31/75
of ethene [2006.01]
A61K 31/755
Polymers containing halogen [2006.01]
A61K 31/76
of vinyl chloride [2006.01]
A61K 31/765
Polymers containing oxygen [2006.01]
A61K 31/77
of oxiranes [2006.01]
A61K 31/775
Phenolic resins [2006.01]
A61K 31/78
of acrylic acid or derivatives thereof [2006.01]
A61K 31/785
Polymers containing nitrogen [2006.01]
A61K 31/787
containing heterocyclic rings having nitrogen as a ring hetero atom [2006.01]
A61K 31/79
Polymers of vinyl pyrrolidone [2006.01]
A61K 31/795
Polymers containing sulfur [2006.01]
A61K 31/80
Polymers containing hetero atoms not provided for in groups A61K 31/755-A61K 31/795 [2006.01]
A61K 33/00
Medicinal preparations containing inorganic active ingredients [2006.01]
A61K 33/02
Ammonia; Compounds thereof [2006.01]
A61K 33/04
Sulfur, selenium or tellurium; Compounds thereof [2006.01]
A61K 33/06
Aluminium, calcium or magnesium; Compounds thereof [2006.01]
A61K 33/08
Oxides; Hydroxides [2006.01]
A61K 33/10
Carbonates; Bicarbonates [2006.01]
A61K 33/12
Magnesium silicate [2006.01]
A61K 33/14
Alkali metal chlorides; Alkaline earth metal chlorides [2006.01]
A61K 33/16
Fluorine compounds [2006.01]
A61K 33/18
Iodine; Compounds thereof [2006.01]
A61K 33/20
Elemental chlorine; Inorganic compounds releasing chlorine [2006.01]
A61K 33/22
Boron compounds [2006.01]
A61K 33/24
Heavy metals; Compounds thereof [2006.01]
A61K 33/26
Iron; Compounds thereof [2006.01]
A61K 33/28
Mercury; Compounds thereof [2006.01]
A61K 33/30
Zinc; Compounds thereof [2006.01]
A61K 33/32
Manganese; Compounds thereof [2006.01]
A61K 33/34
Copper; Compounds thereof [2006.01]
A61K 33/36
Arsenic; Compounds thereof [2006.01]
A61K 33/38
Silver; Compounds thereof [2006.01]
A61K 33/40
Peroxides [2006.01]
A61K 33/42
Phosphorus; Compounds thereof [2006.01]
A61K 33/44
Elemental carbon, e.g. charcoal, carbon black [2006.01]
A61K 35/00
Medicinal preparations containing materials or reaction products thereof with undetermined constitution [2006.01]

Note(s) [2015.01]

  • In this group, classification is made for each active component or material. For each active component or material, classification is then made in the last appropriate place.
  • When classifying in this group, classification is also made in group B01D 15/08 insofar as subject matter of general interest relating to chromatography is concerned.
A61K 35/02
from inanimate materials (carbon A61K 33/44) [2015.01]
A61K 35/04
Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate [2006.01]
A61K 35/06
Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons [2006.01]
A61K 35/08
Mineral waters; Seawater [2015.01]
A61K 35/10
Peat; Amber; Turf; Humus [2015.01]
A61K 35/12
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (uncharacterised stem cells A61K 35/545; vaccines or medicinal preparations containing antigens or antibodies A61K 39/00) [2015.01]

Note(s) [2015.01]

  • If the cells are characterised, classification is made in the group covering the corresponding tissue or tissue of origin.
A61K 35/13
Tumour cells, irrespective of tissue of origin (tumour vaccines A61K 39/00) [2015.01]
A61K 35/14
Blood; Artificial blood (perfluorocarbons A61K 31/02; umbilical cord blood A61K 35/51; haemoglobin A61K 38/42) [2015.01]
A61K 35/15
Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells (presenting a specific antigen A61K 39/00; therapeutic combinations of antibodies, or fragments thereof, and blood-derived cells A61K 39/00) [2015.01]
A61K 35/16
Blood plasma; Blood serum (umbilical cord blood A61K 35/51) [2015.01]
A61K 35/17
Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes (when activated by a specific antigen A61K 39/00) [2015.01]
A61K 35/18
Erythrocytes (haemoglobin A61K 38/42) [2015.01]
A61K 35/19
Platelets; Megacaryocytes [2015.01]
A61K 35/20
Milk; Whey; Colostrum [2006.01]
A61K 35/22
Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland [2015.01]
A61K 35/24
Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid (saliva A61K 35/38) [2015.01]
A61K 35/26
Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes [2015.01]
A61K 35/28
Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells [2015.01]
A61K 35/30
Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue [2015.01]
A61K 35/32
Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane [2015.01]
A61K 35/33
Fibroblasts [2015.01]
A61K 35/34
Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K 35/44) [2015.01]
A61K 35/35
Fat tissue; Adipocytes; Stromal cells; Connective tissues (adipose-derived stem cells A61K 35/28; collagen A61K 38/39) [2015.01]
A61K 35/36
Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K 35/39) [2015.01]
A61K 35/37
Digestive system [2015.01]
A61K 35/38
Stomach; Intestine; Goblet cells; Oral mucosa; Saliva [2015.01]
A61K 35/39
Pancreas; Islets of Langerhans (Langerhans cells of epidermis A61K 35/36) [2015.01]
A61K 35/407
Liver; Hepatocytes [2015.01]
A61K 35/413
Gall bladder; Bile [2015.01]
A61K 35/42
Respiratory system, e.g. lungs, bronchi or lung cells [2015.01]
A61K 35/44
Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells [2015.01]
A61K 35/48
Reproductive organs [2015.01]
A61K 35/50
Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells [2015.01]
A61K 35/51
Umbilical cord; Umbilical cord blood; Umbilical stem cells [2015.01]
A61K 35/52
Sperm; Prostate; Seminal fluid; Leydig cells of testes [2015.01]
A61K 35/54
Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells [2015.01]
A61K 35/545
Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells [2015.01]
A61K 35/55
Glands not provided for in groups A61K 35/22-A61K 35/545, e.g. thyroids, parathyroids or pineal glands [2015.01]
A61K 35/56
Materials from animals other than mammals [2015.01]
A61K 35/57
Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli [2015.01]
A61K 35/58
Reptiles (antigens from snakes  A61K 39/38) [2015.01]
A61K 35/583
Snakes; Lizards, e.g. chameleons (therapeutic use of a snake venom protein A61K 38/00) [2015.01]
A61K 35/586
Turtles; Tortoises, e.g. terrapins [2015.01]
A61K 35/60
Fish, e.g. seahorses; Fish eggs [2006.01]
A61K 35/612
Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles [2015.01]
A61K 35/614
Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish [2015.01]
A61K 35/616
Echinodermata, e.g. starfish, sea cucumbers or sea urchins [2015.01]
A61K 35/618
Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs [2015.01]
A61K 35/62
Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia [2006.01]
A61K 35/63
Arthropods (aquatic crustaceans A61K 35/612) [2015.01]
A61K 35/64
Insects, e.g. bees, wasps or fleas [2015.01]
A61K 35/644
Beeswax; Propolis; Royal jelly; Honey [2015.01]
A61K 35/646
Arachnids, e.g. spiders, scorpions, ticks or mites [2015.01]
A61K 35/648
Myriapods, e.g. centipedes or millipedes [2015.01]
A61K 35/65
Amphibians, e.g. toads, frogs, salamanders or newts [2015.01]
A61K 35/655
Aquatic animals other than those covered by groups A61K 35/57-A61K 35/65 [2015.01]
A61K 35/66
Microorganisms or materials therefrom (fungi, yeasts or candida A61K 36/06) [2015.01]
A61K 35/68
Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma [2006.01]
A61K 35/74
Bacteria (therapeutic use of a bacterial protein A61K 38/00) [2015.01]
A61K 35/741
Probiotics (probiotic yeast, e.g. saccharomyces A61K 36/06) [2015.01]
A61K 35/742
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes [2015.01]
A61K 35/744
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs [2015.01]
A61K 35/745
Bifidobacteria [2015.01]
A61K 35/747
Lactobacilli, e.g. L. acidophilus or L. brevis [2015.01]
A61K 35/748
Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina (algae, microalgae or microphytes A61K 36/02) [2015.01]
A61K 35/76
Viruses; Subviral particles; Bacteriophages [2015.01]
A61K 35/761
Adenovirus [2015.01]
A61K 35/763
Herpes virus [2015.01]
A61K 35/765
Reovirus; Rotavirus [2015.01]
A61K 35/766
Rhabdovirus, e.g. vesicular stomatitis virus [2015.01]
A61K 35/768
Oncolytic viruses not provided for in groups A61K 35/761-A61K 35/766 [2015.01]
A61K 36/00
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines [2006.01]

Note(s) [2006.01]

  • In this group, common names of plants, where given, are presented in brackets following their corresponding Latin names.
  • In this group, it is desirable to add the indexing codes A61K 125/00-A61K 135/00.
A61K 36/02
Algae [2006.01]
A61K 36/03
Phaeophycota or phaeophyta (brown algae), e.g. Fucus [2006.01]
A61K 36/04
Rhodophycota or rhodophyta (red algae), e.g. Porphyra [2006.01]
A61K 36/05
Chlorophycota or chlorophyta (green algae), e.g. Chlorella [2006.01]
A61K 36/06
Fungi, e.g. yeasts [2006.01]
A61K 36/062
Ascomycota [2006.01]
A61K 36/064
Saccharomycetales, e.g. baker's yeast [2006.01]
A61K 36/066
Clavicipitaceae [2006.01]
A61K 36/068
Cordyceps [2006.01]
A61K 36/07
Basidiomycota, e.g. Cryptococcus [2006.01]
A61K 36/074
Ganoderma [2006.01]
A61K 36/076
Poria [2006.01]
A61K 36/09
Lichens [2006.01]
A61K 36/10
Bryophyta (mosses) [2006.01]
A61K 36/11
Pteridophyta or Filicophyta (ferns) [2006.01]
A61K 36/12
Filicopsida or Pteridopsida [2006.01]
A61K 36/126
Drynaria [2006.01]
A61K 36/13
Coniferophyta (gymnosperms) [2006.01]
A61K 36/14
Cupressaceae (Cypress family), e.g. juniper or cypress [2006.01]
A61K 36/15
Pinaceae (Pine family), e.g. pine or cedar [2006.01]
A61K 36/16
Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family) [2006.01]
A61K 36/17
Gnetophyta, e.g. Ephedraceae (Mormon-tea family) [2006.01]
A61K 36/18
Magnoliophyta (angiosperms) [2006.01]
A61K 36/185
Magnoliopsida (dicotyledons) [2006.01]
A61K 36/19
Acanthaceae (Acanthus family) [2006.01]
A61K 36/195
Strobilanthes [2006.01]
A61K 36/20
Aceraceae (Maple family) [2006.01]
A61K 36/21
Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth [2006.01]
A61K 36/22
Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak [2006.01]
A61K 36/23
Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin [2006.01]
A61K 36/232
Angelica [2006.01]
A61K 36/233
Bupleurum [2006.01]
A61K 36/234
Cnidium (snowparsley) [2006.01]
A61K 36/235
Foeniculum (fennel) [2006.01]
A61K 36/236
Ligusticum (licorice-root) [2006.01]
A61K 36/237
Notopterygium [2006.01]
A61K 36/238
Saposhnikovia [2006.01]
A61K 36/24
Apocynaceae (Dogbane family), e.g. plumeria or periwinkle [2006.01]
A61K 36/25
Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax [2006.01]
A61K 36/254
Acanthopanax or Eleutherococcus [2006.01]
A61K 36/258
Panax (ginseng) [2006.01]
A61K 36/26
Aristolochiaceae (Birthwort family), e.g. heartleaf [2006.01]
A61K 36/264
Aristolochia (Dutchman's pipe) [2006.01]
A61K 36/268
Asarum (wild ginger) [2006.01]
A61K 36/27
Asclepiadaceae (Milkweed family), e.g. hoya [2006.01]
A61K 36/28
Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea [2006.01]
A61K 36/282
Artemisia, e.g. wormwood or sagebrush [2006.01]
A61K 36/284
Atractylodes [2006.01]
A61K 36/285
Aucklandia [2006.01]
A61K 36/286
Carthamus (distaff thistle) [2006.01]
A61K 36/287
Chrysanthemum, e.g. daisy [2006.01]
A61K 36/288
Taraxacum (dandelion) [2006.01]
A61K 36/289
Vladimiria [2006.01]
A61K 36/29
Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple [2006.01]
A61K 36/296
Epimedium [2006.01]
A61K 36/30
Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not [2006.01]
A61K 36/31
Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi [2006.01]
A61K 36/315
Isatis, e.g. Dyer's woad [2006.01]
A61K 36/32
Burseraceae (Frankincense family) [2006.01]
A61K 36/324
Boswellia, e.g. frankincense [2006.01]
A61K 36/328
Commiphora, e.g. mecca myrrh or balm of Gilead [2006.01]
A61K 36/33
Cactaceae (Cactus family), e.g. pricklypear or Cereus [2006.01]
A61K 36/34
Campanulaceae (Bellflower family) [2006.01]
A61K 36/342
Adenophora [2006.01]
A61K 36/344
Codonopsis [2006.01]
A61K 36/346
Platycodon [2006.01]
A61K 36/35
Caprifoliaceae (Honeysuckle family) [2006.01]
A61K 36/355
Lonicera (honeysuckle) [2006.01]
A61K 36/36
Caryophyllaceae (Pink family), e.g. babysbreath or soapwort [2006.01]
A61K 36/37
Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree [2006.01]
A61K 36/38
Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort [2006.01]
A61K 36/39
Convolvulaceae (Morning-glory family), e.g. bindweed [2006.01]
A61K 36/40
Cornaceae (Dogwood family) [2006.01]
A61K 36/41
Crassulaceae (Stonecrop family) [2006.01]
A61K 36/42
Cucurbitaceae (Cucumber family) [2006.01]
A61K 36/424
Gynostemma [2006.01]
A61K 36/428
Trichosanthes [2006.01]
A61K 36/43
Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder [2006.01]
A61K 36/44
Ebenaceae (Ebony family), e.g. persimmon [2006.01]
A61K 36/45
Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry [2006.01]
A61K 36/46
Eucommiaceae (Eucommia family), e.g. hardy rubber tree [2006.01]
A61K 36/47
Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) [2006.01]
A61K 36/48
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae [2006.01]
A61K 36/481
Astragalus (milkvetch) [2006.01]
A61K 36/482
Cassia, e.g. golden shower tree [2006.01]
A61K 36/483
Gleditsia (locust) [2006.01]
A61K 36/484
Glycyrrhiza (licorice) [2006.01]
A61K 36/485
Gueldenstaedtia [2006.01]
A61K 36/486
Millettia [2006.01]
A61K 36/487
Psoralea [2006.01]
A61K 36/488
Pueraria (kudzu) [2006.01]
A61K 36/489
Sophora, e.g. necklacepod or mamani [2006.01]
A61K 36/49
Fagaceae (Beech family), e.g. oak or chestnut [2006.01]
A61K 36/50
Fumariaceae (Fumitory family), e.g. bleeding heart [2006.01]
A61K 36/505
Corydalis [2006.01]
A61K 36/51
Gentianaceae (Gentian family) [2006.01]
A61K 36/515
Gentiana [2006.01]
A61K 36/52
Juglandaceae (Walnut family) [2006.01]
A61K 36/53
Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender [2006.01]
A61K 36/532
Agastache, e.g. giant hyssop [2006.01]
A61K 36/533
Leonurus (motherwort) [2006.01]
A61K 36/534
Mentha (mint) [2006.01]
A61K 36/535
Perilla (beefsteak plant) [2006.01]
A61K 36/536
Prunella or Brunella (selfheal) [2006.01]
A61K 36/537
Salvia (sage) [2006.01]
A61K 36/538
Schizonepeta [2006.01]
A61K 36/539
Scutellaria (skullcap) [2006.01]
A61K 36/54
Lauraceae (Laurel family), e.g. cinnamon or sassafras [2006.01]
A61K 36/55
Linaceae (Flax family), e.g. Linum [2006.01]
A61K 36/56
Loganiaceae (Logania family), e.g. trumpetflower or pinkroot [2006.01]
A61K 36/57
Magnoliaceae (Magnolia family) [2006.01]
A61K 36/575
Magnolia [2006.01]
A61K 36/58
Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem) [2006.01]
A61K 36/59
Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead [2006.01]
A61K 36/60
Moraceae (Mulberry family), e.g. breadfruit or fig [2006.01]
A61K 36/605
Morus (mulberry) [2006.01]
A61K 36/61
Myrtaceae (Myrtle family), e.g. teatree or eucalyptus [2006.01]
A61K 36/62
Nymphaeaceae (Water-lily family) [2006.01]
A61K 36/63
Oleaceae (Olive family), e.g. jasmine, lilac or ash tree [2006.01]
A61K 36/634
Forsythia [2006.01]
A61K 36/638
Ligustrum, e.g. Chinese privet [2006.01]
A61K 36/64
Orobanchaceae (Broom-rape family) [2006.01]
A61K 36/65
Paeoniaceae (Peony family), e.g. Chinese peony [2006.01]
A61K 36/66
Papaveraceae (Poppy family), e.g. bloodroot [2006.01]
A61K 36/67
Piperaceae (Pepper family), e.g. Jamaican pepper or kava [2006.01]
A61K 36/68
Plantaginaceae (Plantain Family) [2006.01]
A61K 36/69
Polygalaceae (Milkwort family) [2006.01]
A61K 36/70
Polygonaceae (Buckwheat family), e.g. spineflower or dock [2006.01]
A61K 36/704
Polygonum, e.g. knotweed [2006.01]
A61K 36/708
Rheum (rhubarb) [2006.01]
A61K 36/71
Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal [2006.01]
A61K 36/714
Aconitum (monkshood) [2006.01]
A61K 36/716
Clematis (leather flower) [2006.01]
A61K 36/718
Coptis (goldthread) [2006.01]
A61K 36/72
Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree [2006.01]
A61K 36/725
Ziziphus, e.g. jujube [2006.01]
A61K 36/73
Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn [2006.01]
A61K 36/732
Chaenomeles, e.g. flowering quince [2006.01]
A61K 36/734
Crataegus (hawthorn) [2006.01]
A61K 36/736
Prunus, e.g. plum, cherry, peach, apricot or almond [2006.01]
A61K 36/738
Rosa (rose) [2006.01]
A61K 36/739
Sanguisorba (burnet) [2006.01]
A61K 36/74
Rubiaceae (Madder family) [2006.01]
A61K 36/744
Gardenia [2006.01]
A61K 36/746
Morinda [2006.01]
A61K 36/748
Oldenlandia or Hedyotis [2006.01]
A61K 36/75
Rutaceae (Rue family) [2006.01]
A61K 36/752
Citrus, e.g. lime, orange or lemon [2006.01]
A61K 36/754
Evodia [2006.01]
A61K 36/756
Phellodendron, e.g. corktree [2006.01]
A61K 36/758
Zanthoxylum, e.g. pricklyash [2006.01]
A61K 36/76
Salicaceae (Willow family), e.g. poplar [2006.01]
A61K 36/77
Sapindaceae (Soapberry family), e.g. lychee or soapberry [2006.01]
A61K 36/78
Saururaceae (Lizard's-tail family) [2006.01]
A61K 36/79
Schisandraceae (Schisandra family) [2006.01]
A61K 36/80
Scrophulariaceae (Figwort family) [2006.01]
A61K 36/804
Rehmannia [2006.01]
A61K 36/808
Scrophularia (figwort) [2006.01]
A61K 36/81
Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed [2006.01]
A61K 36/815
Lycium (desert-thorn) [2006.01]
A61K 36/82
Theaceae (Tea family), e.g. camellia [2006.01]
A61K 36/83
Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo [2006.01]
A61K 36/835
Aquilaria [2006.01]
A61K 36/84
Valerianaceae (Valerian family), e.g. valerian [2006.01]
A61K 36/85
Verbenaceae (Verbena family) [2006.01]
A61K 36/855
Clerodendrum, e.g. glorybower [2006.01]
A61K 36/86
Violaceae (Violet family) [2006.01]
A61K 36/87
Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine [2006.01]
A61K 36/88
Liliopsida (monocotyledons) [2006.01]
A61K 36/882
Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus [2006.01]
A61K 36/884
Alismataceae (Water-plantain family) [2006.01]
A61K 36/886
Aloeaceae (Aloe family), e.g. aloe vera [2006.01]
A61K 36/888
Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage [2006.01]
A61K 36/8884
Arisaema, e.g. Jack in the pulpit [2006.01]
A61K 36/8888
Pinellia [2006.01]
A61K 36/889
Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto [2006.01]
A61K 36/8895
Calamus, e.g. rattan [2006.01]
A61K 36/89
Cyperaceae (Sedge family) [2006.01]
A61K 36/8905
Cyperus (flatsedge) [2006.01]
A61K 36/894
Dioscoreaceae (Yam family) [2006.01]
A61K 36/8945
Dioscorea, e.g. yam, Chinese yam or water yam [2006.01]
A61K 36/896
Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus [2006.01]
A61K 36/8962
Allium, e.g. garden onion, leek, garlic or chives [2006.01]
A61K 36/8964
Anemarrhena [2006.01]
A61K 36/8965
Asparagus, e.g. garden asparagus or asparagus fern [2006.01]
A61K 36/8966
Fritillaria, e.g. checker lily or mission bells [2006.01]
A61K 36/8967
Lilium, e.g. tiger lily or Easter lily [2006.01]
A61K 36/8968
Ophiopogon (Lilyturf) [2006.01]
A61K 36/8969
Polygonatum (Solomon's seal) [2006.01]
A61K 36/898
Orchidaceae (Orchid family) [2006.01]
A61K 36/8984
Dendrobium [2006.01]
A61K 36/8988
Gastrodia [2006.01]
A61K 36/899
Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane [2006.01]
A61K 36/8994
Coix (Job's tears) [2006.01]
A61K 36/8998
Hordeum (barley) [2006.01]
A61K 36/90
Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla [2006.01]
A61K 36/902
Sparganiaceae (Bur-reed family) [2006.01]
A61K 36/904
Stemonaceae (Stemona family), e.g. croomia [2006.01]
A61K 36/906
Zingiberaceae (Ginger family) [2006.01]
A61K 36/9062
Alpinia, e.g. red ginger or galangal [2006.01]
A61K 36/9064
Amomum, e.g. round cardamom [2006.01]
A61K 36/9066
Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger [2006.01]
A61K 36/9068
Zingiber, e.g. garden ginger [2006.01]
A61K 38/00
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K 31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K 31/00; ergoline-based peptides A61K 31/48; containing macromolecular compounds having statistically distributed amino acid units A61K 31/74; medicinal preparations containing antigens or antibodies A61K 39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K 47/00) [2006.01]

Note(s) [6]

  • The terms or expressions used in this group follow exactly the definitions given in Note (1) following the title of subclass C07K.
  • Preparations containing fragments of peptides or peptides modified by removal or addition of amino acids, by substitution of amino acids by others, or by combination of these modifications are classified as the preparations containing parent peptides. However, preparations containing fragments of peptides having only four or less amino acids are also classified in groups A61K 38/05-A61K 38/07.
  • Preparations containing peptides prepared by recombinant DNA technology are not classified according to the host, but according to the original peptide expressed, e.g. preparations containing HIV peptide expressed in E. coli are classified with the preparations containing HIV peptides.
A61K 38/01
Hydrolysed proteins; Derivatives thereof [2006.01]
A61K 38/02
Peptides of undefined number of amino acids; Derivatives thereof [2006.01]
A61K 38/03
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [2006.01]
A61K 38/04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (gastrins A61K 38/16, somatostatins A61K 38/31, melanotropins A61K 38/34) [2006.01]
A61K 38/05
Dipeptides [2006.01]
A61K 38/06
Tripeptides [2006.01]
A61K 38/07
Tetrapeptides [2006.01]
A61K 38/08
Peptides having 5 to 11 amino acids [2006.01]
A61K 38/09
Luteinising hormone-releasing hormone (LHRH); Related peptides [2006.01]
A61K 38/10
Peptides having 12 to 20 amino acids [2006.01]
A61K 38/11
Oxytocins; Vasopressins; Related peptides [2006.01]
A61K 38/12
Cyclic peptides [2006.01]
A61K 38/13
Cyclosporins [2006.01]
A61K 38/14
Peptides containing saccharide radicals; Derivatives thereof [2006.01]
A61K 38/15
Depsipeptides; Derivatives thereof [2006.01]
A61K 38/16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [2006.01]
A61K 38/17
from animals; from humans [2006.01]
A61K 38/18
Growth factors; Growth regulators [2006.01]
A61K 38/19
Cytokines; Lymphokines; Interferons [2006.01]
A61K 38/20
Interleukins [2006.01]
A61K 38/21
Interferons [2006.01]
A61K 38/22
Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin A61K 38/33, e.g. corticotropin A61K 38/35) [2006.01]
A61K 38/23
Calcitonins [2006.01]
A61K 38/24
Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) [2006.01]
A61K 38/25
Growth hormone-releasing factor (GH-RF) (Somatoliberin) [2006.01]
A61K 38/26
Glucagons [2006.01]
A61K 38/27
Growth hormone (GH) (Somatotropin) [2006.01]
A61K 38/28
Insulins [2006.01]
A61K 38/29
Parathyroid hormone (parathormone); Parathyroid hormone-related peptides [2006.01]
A61K 38/30
Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2 [2006.01]
A61K 38/31
Somatostatins [2006.01]
A61K 38/32
Thymopoietins [2006.01]
A61K 38/33
derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin [2006.01]
A61K 38/34
Melanocyte stimulating hormone (MSH), e.g. alpha- or beta-melanotropin [2006.01]
A61K 38/35
Corticotropin (ACTH) [2006.01]
A61K 38/36
Blood coagulation or fibrinolysis factors [2006.01]
A61K 38/37
Factors VIII [2006.01]
A61K 38/38
Albumins [2006.01]
A61K 38/39
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) [2006.01]
A61K 38/40
Transferrins, e.g. lactoferrins, ovotransferrins [2006.01]
A61K 38/41
Porphyrin- or corrin-ring-containing peptides [2006.01]
A61K 38/42
Haemoglobins; Myoglobins [2006.01]
A61K 38/43
Enzymes; Proenzymes; Derivatives thereof [2006.01]

Note(s) [6]

  • In this group:
    • proenzymes are classified with the corresponding enzymes;
    • enzymes are generally categorised according to the "Nomenclature and Classification of Enzymes" of the International Commission of Enzymes. Where appropriate, this designation appears in the subgroups below in parenthesis.
A61K 38/44
Oxidoreductases (1) [2006.01]
A61K 38/45
Transferases (2) [2006.01]
A61K 38/46
Hydrolases (3) [2006.01]
A61K 38/47
acting on glycosyl compounds (3.2), e.g. cellulases, lactases [2006.01]
A61K 38/48
acting on peptide bonds (3.4) [2006.01]
A61K 38/49
Urokinase; Tissue plasminogen activator [2006.01]
A61K 38/50
acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase [2006.01]
A61K 38/51
Lyases (4) [2006.01]
A61K 38/52
Isomerases (5) [2006.01]
A61K 38/53
Ligases (6) [2006.01]
A61K 38/54
Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K 38/44-A61K 38/46 or A61K 38/51-A61K 38/53 [2006.01]
A61K 38/55
Protease inhibitors [2006.01]
A61K 38/56
from plants [2006.01]
A61K 38/57
from animals; from humans [2006.01]
A61K 38/58
from leeches, e.g. hirudin, eglin [2006.01]
A61K 39/00
Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53) [2006.01]

Note(s) [3]

  • Preparation of antigen or antibody compositions is also classified in subclass C12N, if the step of cultivating the microorganism is of interest.
  • Groups A61K 39/002-A61K 39/12 cover preparations containing protozoa, bacteria, viruses, or subunits thereof, e.g. membrane parts.
A61K 39/002
Protozoa antigens [2006.01]
A61K 39/005
Trypanosoma antigens [2006.01]
A61K 39/008
Leishmania antigens [2006.01]
A61K 39/012
Coccidia antigens [2006.01]
A61K 39/015
Hemosporidia antigens, e.g. Plasmodium antigens [2006.01]
A61K 39/018
Babesia antigens, e.g. Theileria antigens [2006.01]
A61K 39/02
Bacterial antigens [2006.01]
A61K 39/04
Mycobacterium, e.g. Mycobacterium tuberculosis [2006.01]
A61K 39/05
Corynebacterium; Propionibacterium [2006.01]
A61K 39/07
Bacillus [2006.01]
A61K 39/08
Clostridium, e.g. Clostridium tetani [2006.01]
A61K 39/085
Staphylococcus [2006.01]
A61K 39/09
Streptococcus [2006.01]
A61K 39/095
Neisseria [2006.01]
A61K 39/10
Brucella; Bordetella, e.g. Bordetella pertussis [2006.01]
A61K 39/102
Pasteurella; Haemophilus [2006.01]
A61K 39/104
Pseudomonas [2006.01]
A61K 39/106
Vibrio; Campylobacter [2006.01]
A61K 39/108
Escherichia; Klebsiella [2006.01]
A61K 39/112
Salmonella; Shigella [2006.01]
A61K 39/114
Fusobacterium [2006.01]
A61K 39/116
Polyvalent bacterial antigens [2006.01]
A61K 39/118
Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci [2006.01]
A61K 39/12
Viral antigens [2006.01]
A61K 39/125
Picornaviridae, e.g. calicivirus [2006.01]
A61K 39/13
Poliovirus [2006.01]
A61K 39/135
Foot-and-mouth disease virus [2006.01]
A61K 39/145
Orthomyxoviridae, e.g. influenza virus [2006.01]
A61K 39/15
Reoviridae, e.g. calf diarrhea virus [2006.01]
A61K 39/155
Paramyxoviridae, e.g. parainfluenza virus [2006.01]
A61K 39/165
Mumps or measles virus [2006.01]
A61K 39/17
Newcastle disease virus [2006.01]
A61K 39/175
Canine distemper virus [2006.01]
A61K 39/187
Hog cholera virus [2006.01]
A61K 39/193
Equine encephalomyelitis virus [2006.01]
A61K 39/20
Rubella virus [2006.01]
A61K 39/205
Rhabdoviridae, e.g. rabies virus [2006.01]
A61K 39/21
Retroviridae, e.g. equine infectious anemia virus [2006.01]
A61K 39/215
Coronaviridae, e.g. avian infectious bronchitis virus [2006.01]
A61K 39/225
Porcine transmissible gastroenteritis virus [2006.01]
A61K 39/23
Parvoviridae, e.g. feline panleukopenia virus [2006.01]
A61K 39/235
Adenoviridae [2006.01]
A61K 39/245
Herpetoviridae, e.g. herpes simplex virus [2006.01]
A61K 39/25
Varicella-zoster virus [2006.01]
A61K 39/255
Marek's disease virus [2006.01]
A61K 39/265
Infectious rhinotracheitis virus [2006.01]
A61K 39/27
Equine rhinopneumonitis virus [2006.01]
A61K 39/275
Poxviridae, e.g. avipoxvirus [2006.01]
A61K 39/285
Vaccinia virus or variola virus [2006.01]
A61K 39/29
Hepatitis virus [2006.01]
A61K 39/295
Polyvalent viral antigens (vaccinia virus or variola virus A61K 39/285); Mixtures of viral and bacterial antigens [2006.01]
A61K 39/35
Allergens [2006.01]
A61K 39/36
from pollen [2006.01]
A61K 39/38
Antigens from snakes [2006.01]
A61K 39/385
Haptens or antigens, bound to carriers [2006.01]
A61K 39/39
characterised by the immunostimulating additives, e.g. chemical adjuvants [2006.01]
A61K 39/395
Antibodies (agglutinins A61K 38/36); Immunoglobulins; Immune serum, e.g. antilymphocytic serum [2006.01]
A61K 39/40
bacterial [2006.01]
A61K 39/42
viral [2006.01]
A61K 39/44
Antibodies bound to carriers [2006.01]
A61K 41/00
Medicinal preparations obtained by treating materials with wave energy or particle radiation (A61K 31/59 takes precedence) [2006.01]
A61K 45/00
Medicinal preparations containing active ingredients not provided for in groups A61K 31/00-A61K 41/00 [2006.01]
A61K 45/06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca [2006.01]
A61K 45/08
Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance [2006.01]
A61K 47/00
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient [2006.01]
A61K 47/02
Inorganic compounds [2006.01]
A61K 47/04
Non-metals; Compounds thereof [2006.01]
A61K 47/06
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite [2006.01]
A61K 47/08
containing oxygen [2006.01]
A61K 47/10
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers [2006.01]
A61K 47/12
Carboxylic acids; Salts or anhydrides thereof [2006.01]
A61K 47/14
Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters [2006.01]
A61K 47/16
containing nitrogen [2006.01]
A61K 47/18
Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids [2006.01]
A61K 47/20
containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids [2006.01]
A61K 47/22
Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones [2006.01]
A61K 47/24
containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids [2006.01]
A61K 47/26
Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin [2006.01]
A61K 47/28
Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid [2006.01]
A61K 47/30
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates [2006.01]
A61K 47/32
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers [2006.01]
A61K 47/34
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K 47/10 takes precedence) [2017.01]
A61K 47/36
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin [2006.01]
A61K 47/38
Cellulose; Derivatives thereof [2006.01]
A61K 47/40
Cyclodextrins; Derivatives thereof [2006.01]
A61K 47/42
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids A61K 47/18; polyamino acids A61K 47/34) [2017.01]
A61K 47/44
Oils, fats or waxes according to two or more groups of A61K 47/02-A61K 47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K 47/14) [2017.01]
A61K 47/46
Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts [2006.01]
A61K 47/48(transferred to A61K 47/50-A61K 47/69)
A61K 47/50
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates [2017.01]
A61K 47/51
the non-active ingredient being a modifying agent [2017.01]
A61K 47/52
the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient [2017.01]
A61K 47/54
the modifying agent being an organic compound [2017.01]
A61K 47/55
the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds [2017.01]
A61K 47/56
the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule [2017.01]
A61K 47/58
obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin [2017.01]
A61K 47/59
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes [2017.01]
A61K 47/60
the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol [2017.01]
A61K 47/61
the organic macromolecular compound being a polysaccharide or a derivative thereof [2017.01]
A61K 47/62
the modifying agent being a protein, peptide or polyamino acid [2017.01]
A61K 47/64
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K 47/65) [2017.01]
A61K 47/65
Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers [2017.01]
A61K 47/66
the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells [2017.01]
A61K 47/68
the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment [2017.01]
A61K 47/69
the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit [2017.01]
A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy [2006.01]
A61K 49/00
Preparations for testing in vivo [2006.01]
A61K 49/04
X-ray contrast preparations [2006.01]
A61K 49/06
Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations [2006.01]
A61K 49/08
characterised by the carrier [2006.01]
A61K 49/10
Organic compounds [2006.01]
A61K 49/12
Macromolecular compounds [2006.01]
A61K 49/14
Peptides, e.g. proteins [2006.01]
A61K 49/16
Antibodies; Immunoglobulins; Fragments thereof [2006.01]
A61K 49/18
characterised by a special physical form, e.g. emulsions, microcapsules, liposomes [2006.01]
A61K 49/20
containing free radicals [2006.01]
A61K 49/22
Echographic preparations; Ultrasound imaging preparations [2006.01]
A61K 50/00
Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ECG) or for transcutaneous drug administration [2006.01]
A61K 51/00
Preparations containing radioactive substances for use in therapy or testing in vivo [2006.01]

Note(s) [6]

A61K 51/02
characterised by the carrier [2006.01]
A61K 51/04
Organic compounds [2006.01]
A61K 51/06
Macromolecular compounds [2006.01]
A61K 51/08
Peptides, e.g. proteins [2006.01]
A61K 51/10
Antibodies or immunoglobulins; Fragments thereof [2006.01]
A61K 51/12
characterised by a special physical form, e.g. emulsion, microcapsules, liposomes [2006.01]
Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance. [6]
A61K 101/00
Radioactive non-metals [2006.01]
A61K 101/02
Halogens [2006.01]
A61K 103/00
Radioactive metals [2006.01]
A61K 103/10
Technetium; Rhenium [2006.01]
A61K 103/20
Indium [2006.01]
A61K 103/30
Rare earths [2006.01]
A61K 103/32
Yttrium [2006.01]
A61K 103/34
Gadolinium [2006.01]
A61K 103/36
Ytterbium [2006.01]
A61K 103/40
Actinides [2006.01]
Indexing scheme associated with group A61K 36/00, relating to plant parts with medicinal activity. [2006.01]
A61K 125/00
Containing or obtained from roots, bulbs, tubers, corms or rhizomes [2006.01]
A61K 127/00
Containing or obtained from leaves [2006.01]
A61K 129/00
Containing or obtained from bark [2006.01]
A61K 131/00
Containing or obtained from seeds, nuts, fruits or grains [2006.01]
A61K 133/00
Containing or obtained from flowers or blossoms [2006.01]
A61K 135/00
Containing or obtained from stems, stalks, branches, twigs or shoots [2006.01]